全部分类
  • PI3Kα/mTOR-IN-1
PI3Kα/mTOR-IN-1的可视化放大

PI3Kα/mTOR-IN-1

PI3Kα/mTOR-IN-1 是一种有效的 PI3Kα/mTOR 双重抑制剂,在细胞实验中对 PI3Kα 的 IC50 值为 7 nM,在体外酶实验中对 mTOR 和 PI3Kα 的 Ki 值分别为 10.6 nM 和 12.5 nM。

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

PI3Kα/mTOR-IN-1的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 1mg
    ¥8412.00
    6730.00
    - +
  • 5mg
    ¥16662.00
    13330.00
    - +
  • 10mg
    ¥28312.00
    22650.00
    - +
  • 20mg
    ¥50012.00
    40010.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajce58060
  • CAS: 1013098-90-2
  • 别名: PI3K伪/MTOR-IN-1
  • 分子式: C16H18N6O
  • 分子量: 310.35
  • 纯度: >98%
  • 溶解度: Soluble in DMSO
  • 储存: Store at -20°C
  • 库存: 现货

Background

PI3Kα/mTOR-IN-1 is a potent PI3Kα/mTOR dual inhibitor, with an IC50 of 7 nM for PI3Kα in a cell assay, and Kis of 10.6 nM and 12.5 nM for mTOR and PI3Kα in a cell free assay , respectively. PI3Kα|7 nM (IC50, Cell Assay)|PI3Kα|12.5 nM (Ki)|mTOR|10.6 nM (Ki)


PI3Kα/mTOR-IN-1 exhibits potent activity against PI3Kα and mTOR, high LipE, good kinase selectivity and robust ADMET properties[1].


PI3Kα/mTOR-IN-1 exhibits low HLM ER, but it is highly cleared in rat liver microsome (RLM) with ER of 0.88. PI3Kα/mTOR-IN-1 exhibits moderate clearance, moderate Vdss, T1/2 of 0.9 h, and good oral bioavailability[1].


[1]. Le PT, et al. Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Kα and mTOR. Bioorg Med Chem Lett. 2012 Aug 1;22(15):5098-103.

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算